Pfizer had FDA Fast Track approval in July which means they could start reviewing it early as the trial progressed. In a sensible process all those hundreds of

Pfizer had FDA Fast Track approval in July which means they could start reviewing it early as the trial progressed. In a sensible process all those hundreds of people should have reviewed and discussed nearly everything but the final numbers prior to Nov. 20 and been ready to plug in the numbers as soon as they came out.